Publications by authors named "Sebastien Verteneuil"

Article Synopsis
  • Alzheimer's disease (AD) currently has no curative treatment, with existing medications only alleviating symptoms; targeting the enzyme cPLA-IVA may provide a new therapeutic avenue.* -
  • Researchers identified a peptide, PLP25, that inhibits cPLA-IVA using phage display technology and validated its effects on important biomarkers and spatial memory in APP/PS1 mice.* -
  • The study found that PLP25 decreased cPLA-IVA activity and associated amyloid plaques while improving cognitive abilities and receptor expression, suggesting its potential as a treatment for AD.*
View Article and Find Full Text PDF

Previous research has shown that cyclin-dependent kinases (Cdks) that play physiological roles in cell cycle regulation become activated in post-mitotic neurons after ischemic stroke, resulting in apoptotic neuronal death. In this article, we report our results using the widely used oxygen-glucose deprivation (OGD) in vitro model of ischemic stroke on primary mouse cortical neurons to investigate whether Cdk7, as part of the Cdk-activating kinase (CAK) complex that activates cell cycle Cdks, might be a regulator of ischemic neuronal death and may potentially constitute a therapeutic target for neuroprotection. We found no evidence of neuroprotection with either pharmacological or genetic invalidation of Cdk7.

View Article and Find Full Text PDF

Blood-brain barrier (BBB) crossing and brain penetration are really challenging for the delivery of therapeutic agents and imaging probes. The development of new crossing strategies is needed, and a wide range of approaches (invasive or not) have been proposed so far. The receptor-mediated transcytosis is an attractive mechanism, allowing the non-invasive penetration of the BBB.

View Article and Find Full Text PDF

A persistent dogma in neuroscience supported the idea that terminally differentiated neurons permanently withdraw from the cell cycle. However, since the late 1990s, several studies have shown that cell cycle proteins are expressed in post-mitotic neurons under physiological conditions, indicating that the cell cycle machinery is not restricted to proliferating cells. Moreover, many studies have highlighted a clear link between cell cycle-related proteins and neurological disorders, particularly relating to apoptosis-induced neuronal death.

View Article and Find Full Text PDF

Neural stem cells give rise to granule dentate neurons throughout life in the hippocampus. Upon activation, these stem cells generate fast proliferating progenitors that complete several rounds of divisions before differentiating into neurons. Although the mechanisms regulating the activation of stem cells have been intensively studied, little attention has been given so far to the intrinsic machinery allowing the expansion of the progenitor pool.

View Article and Find Full Text PDF
Article Synopsis
  • Cell cycle proteins are found in dividing cells but also have roles in cell death, especially in neurons after injury.
  • Cdk1, a key regulator of the cell cycle, was linked to neuronal death after ischemic conditions; its inhibition showed potential for neuroprotection.
  • Both genetic models (Cdk1-cKO mice) and pharmacological approaches (R-roscovitine) indicated that targeting Cdk1 could lead to new therapies to protect neurons from ischemic damage.
View Article and Find Full Text PDF

Stroke affects one in every six people worldwide, and is the leading cause of adult disability. After stroke, some limited spontaneous recovery occurs, the mechanisms of which remain largely unknown. Multiple, parallel approaches are being investigated to develop neuroprotective, reparative and regenerative strategies for the treatment of stroke.

View Article and Find Full Text PDF